Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Simtuzumab |
| Trade Name | |
| Synonyms | AB0024|GS-6624 |
| Drug Descriptions |
Simtuzumab (GS-6624) is a humanized monoclonal antibody against lysyl oxidase-like 2 (LOXL2), with potential antineoplastic activity (PMID: 28246207). |
| DrugClasses | |
| CAS Registry Number | 1318075-13-6 |
| NCIT ID | C91735 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fluorouracil + Irinotecan + Leucovorin + Simtuzumab | Fluorouracil Irinotecan Leucovorin Simtuzumab | 0 | 0 |
| Simtuzumab | Simtuzumab | 0 | 0 |